Scientific Programme

Expand All +
  • Day 1

    Thursday 3 October

    • Welcome from Siegfried Kasper, CINP President
    • Konstantinos Fountoulakis, CINP 2019 Local Organising Chair
    • Constantin Soldatos, Honorary President of the World Federation of Societies of Biological Psychiatry
    • George Christodoulou, Honorary President of the Hellenic Psychiatric Association and President of the Society of Preventive Psychiatry
    Where
    Olympia Hall

    • Chair: Siegfried Kasper, Medical University of Vienna, Austria and Konstantinos Fountoulakis, Aristotle University of Thessaloniki, Greece
    • Speaker: John H. Krystal, Yale School of Medicine, USA
    Keynote Lecture
    Where
    Olympia Hall

  • Speaker: Professor Celso Arango
    Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañon
    Ibiza 43, 28009 Madrid, Spain
    Where
    Olympia Foyer

    • Chairs: Carlos Zarate, National Institute of Mental Health, USA, Giorgos Alevizopoulos, Aghioi Anargyroi Hospital, Greece
    • Mechanisms of antidepressant response - Francesc Artigas, CSIC, Spain
    • Genetics of antidepressant response - Alessandro Serretti, University of Bologna, Italy
    • Rapid acting antidepressants - Carlos Zarate, National Institute of Mental Health, USA
    Symposium Lecture
    Where
    Olympia Hall

    • Chair: Elias Eriksson, University of Gothenburg, Sweden and TBC, Greece
    • Speaker: John H. Krystal, Yale School of Medicine, USA
    • Joseph Zohar, Sheba Medical Center, Israel
    Young Scientist Forum
    Where
    Templar's Hall

    • Chair: Georgia Salanti, Universität Bern, Switzerland and Ioannis Michopoulos, National and Kapodistrian University of Athens, Greece
    • Speaker: Alan Frazer, UT Health San Antonio, USA
    Meet the Expert
    Where
    Attica Hall

    • Chairs: Alan Frazer, UT Health San Antonio, USA and Thanasios Douzenis, National and Kapodistrian University of Athens, Greece
    • 13:00-13:15: Towards clinical applications of fMRI - replicating global brain connectivity in treatment resistant depression. Christoph Kraus, National Institute of Mental Health, USA
    • 13:20-13:35 Developing imaging markers of depression and treatment response. Jennifer Evans, National Institute of Mental Health, USA
    • 13.40-13:55 Identification of neuroinflammatory markers via metabolomic profiling of a ketamine or placebo crossover trial in patients with treatment-resistant mood disorders. Bashkim Kadriu, National Institute of Mental Health, USA
    • 14:00-14:15 Development of next generation seizure therapy for treatment resistant depression. Zhi-De Deng, National Institute of Mental Health, USA
    • 14:20-14:30 Synopsis and outlook in developments. Discussant: Carlos Zarate, National Institute of Mental Health, USA
    Satellite Symposium
    Where
    Templar's Hall

    • Chair: Carol Tamminga, UT Southwestern, USA and Nikos Stefanis, National and Kapodistrian University of Athens, Greece
    • 13:00-13:25: New antipsychotic drugs. Dr. Carol Tamminga, UT Southwestern, USA
    • 13:30-13:55: Controversies in literature in antipsychotic treatment - Konstantinos Fountoulakis, Aristotle University of Thessaloniki, Greece
    • 14:00-14:25: Antipsychotic Polypharmacy: Is it a dirty little secret or a fashion? - Shih-Ku Lin, Taipei Medical University, Taiwan
    Symposium Lecture
    Where
    Olympia Hall

  • Speakers: Siegfried Kasper, Daniel Souery, Andreas Papadopoulos, Lucie Bartova, Andrew J. Cutler
    13:00 - 13:05 Welcome & Introduction - Chair: Siegfried Kasper (Austria)
    13:05 - 13:45 When to act: Optimising treatment in MDD - Daniel Souery (Belgium) and Andreas Papadopoulos (UK)
    13:45 - 14:25 How to act: Are fast-acting treatments the future? - Lucie Bartova (Austria) and Andrew J. Cutler (USA)
    14:25 - 14:30 Close - Chair: Siegfried Kasper (Austria)
    Meet the Expert
    Where
    Attica Hall

    • Chair: Shih-Ku Lin, Taipei Medical University, Taiwan and Constantin Soldatos, University of Athens, Greece
    • Speaker: Tarek Okasha, Ain Shams University, Cairo, Egypt
    Keynote Lecture
    Where
    Olympia Hall

  • Speaker: Professor David Taylor MSc PhD FFRPS FRPharmS FRCPEdin
    Director of Pharmacy and Pathology; Head of Pharmaceutical Sciences Clinical Academic Group, King's Health Partners South London and Maudsley NHS Foundation Trust Pharmacy Department | Maudsley Hospital | Denmark Hill | London | SE5 8AZ
    Where
    Olympia Foyer

    • Organized by the Hellenic Psychiatric Association
    • Chair: Charalampos Touloumis, Psychiatric Hospital of Attica, Greece and Christos Tsopelas, Psychiatric Hospital of Attica, Greece
    • 16:00-16:25: Add-on treatment in schizophrenia spectrum disorders by Charalampos Touloumis, Psychiatric Hospital of Attica, Greece
    • 16:30-16:55: Add-on treatment in treatment resistant depression by Christos Tsopelas, Psychiatric Hospital of Attica, Greece and Maria Dimitraka, Psychiatric Hospital of Attica, Greece
    • 17:00-17:25: Clinical challenges in dual diagnosis patients by Georgios Tzeferakos, Hellenic Agency Against Drugs, Greece
    Symposium Lecture
    Where
    Olympia Hall

    • Chairs: Elias Eriksson, University of Gothenburg, Sweden
    • Joseph Zohar, Sheba Medical Center, Israel
    • Pierre Blier, University of Ottawa, Canada
    • Giorgos Alevizopoulos, Aghioi Anargyroi Hospital, Greece
    Where
    Olympia Foyer

  • Day 2

    Friday 4 October

    • Chair: Hans-Jürgen Möller, Ludwig-Maximilians-University, Germany and Dimitris Dikeos, National and Kapodistrian University of Athens Greece
    • Speaker: Siegfried Kasper, Medical University of Vienna, Austria
    Keynote Lecture
    Where
    Olympia Hall

    • Rafaelsen Young Investigators Awards presented by Siegfried Kasper, CINP President
    Where
    Olympia Hall

    • Chair: Larry Klassen, Eden Mental Health Centre, Canada and Eva-Maria Tsapakis, 'Aghios Charalambos' Mental Health Clinic, Greece
    • 10:30-10:55: Treatment of ADHD: a pharmacoepidemiological approach - Zheng Chang, Karolinska Institutet, Sweden
    • 11:00-11:25: ADHD Treatment in adults - Larry Klassen, Eden Mental Health Centre, Canada
    • 11:30-11:55: Meta-analysis in ADHD response - Andrea Cipriani, Oxford University, United Kingdom
    Symposium Lecture
    Where
    Olympia Hall

    • Chair: Jennifer Evans, National Institute of Mental Health, USA and Dimitris Dikeos, National and Kapodistrian University of Athens, Greece
    • Speaker: Konstantinos Fountoulakis, Aristotle University of Thessaloniki, Greece
    Meet the Expert
    Where
    Attica Hall

    • Chairs: Andrew Krystal, University of California, San Francisco, USA, Maria Samakouri, Democritus University of Thrace, Greece
    • Speakers: Joseph Zohar, Sheba Medical Center, Israel
    • Pierre Blier, University of Ottawa, Canada
    • Hans-Jurgen Moller, Ludwig-Maximilians-University, Germany
    Workshop
    Where
    Templar's Hall

    • Chair: Pierre Blier, University of Ottawa, Canada and Nikos Stefanis, National and Kapodistrian University of Athens, Greece
    • Speaker: Elias Eriksson, University of Gothenburg, Sweden
    Keynote Lecture
    Where
    Olympia Hall

    • Chair: Alessandro Serretti, University of Bologna, Italy and Ioannis Nimatoudis, Artistotle University of Thessaloniki, Greece
    • Speaker: Larry Klassen, Eden Mental Health Centre, Canada
    Meet the Expert
    Where
    Attica Hall

    • Chair: Dietmar Winkler, Medical University of Vienna, Austria and Anthanasios Douzenis, National and Kapodistrian University of Athens, Greece
    • Speaker: Pierre Blier, University of Ottawa, Canada
    Workshop
    Where
    Templar's Hall

    • Chair: Gabriella Gobbi, McGill University, Canada and Theofanis Vorvokalos, Democritus University of Thrace, Greece
    • 14:30-14:55: Orexin receptor antagonists: state of the art – Andrew Krystal, University of California, San Francisco, USA
    • 15:00-15:25: Benzodiazepines pro and contra – Pierre Michel Llorca, CHU Clermont-Ferrand, France
    • 15:30-15:55: Selective melatonin MT2 receptor agonists for the treatment of sleep disorders - Gabriella Gobbi, McGill University, Canada
    Symposium Lecture
    Where
    Olympia Hall

  • Scientific committee: Siegfried Kasper (Austria)
    Moderator: Siegfried Kasper (Austria)
    Speakers: Lucie Bartova (Austria)
    16:10–16:13 Characterisation of the MDD patient - Lucie Bartova (Austria) 16:13–16:20 Current challenges of when and how to treat - Lucie Bartova (Austria) 16:20–16:25 Moderated Q&A session - Moderator: Siegfried Kasper (Austria) and Lucie Bartova (Austria)
    Where
    Olympia Foyer

    • Chair: John H. Krystal, Yale School of Medicine, USA and Ioannis Michopoulos, National and Kapodistrian University of Athens, Greece
    • Speaker: Stephen Kanes, SAGE Therapeutics Inc., USA
    Keynote Lecture
    Where
    Olympia Hall

    • Chairs: Konstantinos Fountoulakis, Aristotle University of Thessaloniki, Greece
    • Gabriella Gobbi, McGill University, Canada
    • Francesc Artigas, CSIC, Spain
    • TBC, Greece
    Where
    Olympia Foyer

  • Day 3

    Saturday 5 October

    • Chair: Maurizio Fava, Massachusetts General Hospital, USA
    • Speaker: Pierre Blier, University of Ottawa, Canada
    Keynote Lecture
    Where
    Olympia Hall

    • Speakers:
    • Susan J. Young, BSc (Hons), PhD, DClinPsy, PhD, CSci, AFBPS is the Director of Psychology Services Limited and an Honorary Professor at both Reykjavic University, Iceland and Bucks New University, UK. She is President of the UK ADHD Partnership; Vice-President of the UK Adult ADHD Network; and is Trustee of The ADHD Foundation, UK
    • Larry J. Klassen, MD, FRCPC, BSc is a psychiatrist and Research Chair at the Eden Mental Health Centre in Winkler, Manitoba, Canada. He specialises in the treatment of adults with Mood and Anxiety Disorders, as well as ADHD, and is involved in the ongoing education of psychiatry residents and medical students.
    • Josep Antoni Ramos-Quiroga, MD, PhD is a Professor of Psychiatry at Universitat Autònoma de Barcelona, Spain and is Head of the Department of Psychiatry at Hospital Universitari Vall d’Hebron, Spain.
    Meet the Expert
    Where
    Templar's Hall

    • Chair: Pierre Michel Llorca, CHU Clermon-Ferrand, France and Nikos Stefanis, National and Kapodistrian University of Athens, Greece
    • 10:30-10:55: Digital psychopharmacology - Konstantinos Pastiadis, Aristotle University of Thessaloniki, Greece
    • 11:00-11:25: New findings from old studies: Insights into the evidence of efficacy, tolerability and acceptability of antidepressants - Georgia Salanti, Universität Bern, Switzerland
    • 11:30-11:55: Evidence does not equal evidence - Hans-Jürgen Möller, Ludwig-Maximilians-University, Germany
    Symposium Lecture
    Where
    Olympia Hall

    • Chairs: Joseph Zohar, Sheba Medical Center, Israel and Athanasios Douzenis, National and Kapodistrian University of Athens, Greece
    • Speaker: Erich Seifritz, Psychiatrische Universitätsklinik Zürich, Switzerland
    Workshop
    Where
    Attica Hall

    • Chair: Erich Seifritz, Psychiatrische Universitätsklinik Zürich, Switzerland
    • Speaker: Maurizio Fava, Massachusetts General Hospital, USA
    Keynote Lecture
    Where
    Olympia Hall